Results 171 to 180 of about 13,660 (185)

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2017
Decai Tian, Fu-Dong Shi, Chunsheng Yang   +2 more
exaly  

Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case report

General Hospital Psychiatry, 2010
Bruce Cree, Josh Woolley
exaly  

The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates

Multiple Sclerosis Journal, 2017
Tom Solomon, Anu Jacob, Kerry Mutch
exaly  

Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders

Multiple Sclerosis Journal, 2017
Su-Hyun Kim, Jae-Won Hyun, Eun Young Park   +2 more
exaly  

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

Therapeutic Advances in Neurological Disorders, 2016
Nicolas Collongues, Jérôme De Sèze
exaly  

NEUROMYELITIS OPTICA

The Journal of Nervous and Mental Disease, 1939
openaire   +1 more source

Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints

Multiple Sclerosis Journal, 2016
Su-Hyun Kim, Ho Jin Kim, Jae-Won Hyun
exaly  

Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2014
Byung-Jo Kim, Su-Hyun Kim, So-Young Huh   +2 more
exaly  

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica

Multiple Sclerosis Journal, 2007
Caroline Papeix, C Pierrot-Deseilligny, T Moreau   +2 more
exaly  

Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal, 2016
Takashi Ohashi, Ichiro Nakashima, Tatsuro Misu   +2 more
exaly